Palatin Technologies, Inc. (PTN)
10.16
+0.47
(+4.85%)
USD |
NASDAQ |
Aug 24, 16:00
10.30
+0.14
(+1.38%)
After-Hours: 20:00
Palatin Technologies Shareholders Equity (Quarterly) : 10.59M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 10.59M |
| December 31, 2025 | 11.47M |
| September 30, 2025 | 0.3964M |
| June 30, 2025 | -4.777M |
| March 31, 2025 | -6.387M |
| December 31, 2024 | -6.381M |
| September 30, 2024 | -7.686M |
| June 30, 2024 | -0.1115M |
| March 31, 2024 | 1.579M |
| December 31, 2023 | -11.38M |
| September 30, 2023 | -4.889M |
| June 30, 2023 | -1.980M |
| March 31, 2023 | 9.592M |
| December 31, 2022 | 16.34M |
| September 30, 2022 | 8.449M |
| June 30, 2022 | 16.27M |
| March 31, 2022 | 28.09M |
| December 31, 2021 | 35.20M |
| September 30, 2021 | 42.97M |
| June 30, 2021 | 49.65M |
| March 31, 2021 | 62.88M |
| December 31, 2020 | 67.84M |
| September 30, 2020 | 76.98M |
| June 30, 2020 | 80.17M |
| March 31, 2020 | 86.69M |
| Date | Value |
|---|---|
| December 31, 2019 | 91.37M |
| September 30, 2019 | 96.12M |
| June 30, 2019 | 100.55M |
| March 31, 2019 | 16.07M |
| December 31, 2018 | 21.14M |
| September 30, 2018 | 25.17M |
| June 30, 2018 | 26.96M |
| March 31, 2018 | 10.23M |
| December 31, 2017 | 9.626M |
| September 30, 2017 | 5.976M |
| June 30, 2017 | -5.165M |
| March 31, 2017 | -18.86M |
| December 31, 2016 | -15.96M |
| September 30, 2016 | -21.77M |
| June 30, 2016 | -17.59M |
| March 31, 2016 | -4.697M |
| December 31, 2015 | 7.475M |
| September 30, 2015 | 20.23M |
| June 30, 2015 | 12.20M |
| March 31, 2015 | 23.98M |
| December 31, 2014 | 32.68M |
| September 30, 2014 | 10.80M |
| June 30, 2014 | 9.789M |
| March 31, 2014 | 13.99M |
| December 31, 2013 | 15.26M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Decoy Therapeutics, Inc. | 4.321M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.23M |
| Total Liabilities (Quarterly) | 2.634M |
| Debt to Equity Ratio | 0.0271 |
| Current Ratio | 5.042 |
| Net Debt Paydown Yield | 0.05% |